Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Xanthouli (Heidelberg, Germany), N. Milde (Heidelberg, Germany), V. Theobald (Heidelberg, Germany), A. Marra (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), C. Nagel (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany), N. Blank (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany), S. Harutyunova (Heidelberg, Germany), H. Lorenz (Heidelberg, Germany), E. Grünig (Heidelberg, Germany). Hemodynamic phenotypes in systemic sclerosis patients screened for pulmonary hypertension – impact of the new PH-definition. 5464

Member's Comments

No comment yet.

Related content which might interest you: Identifying early pulmonary arterial hypertension in patients with systemic sclerosis Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018 Year: 2018 Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening Source: Eur Respir Rev 2011; 20: 270-276 Year: 2011 Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis Source: Eur Respir J, 51 (4) 1701197; 10.1183/13993003.01197-2017 Year: 2018 A screening protocol for pulmonary hypertension in systemic sclerosis identifies patients with pulmonary hypertension on exercise Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004 Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018 Year: 2018 Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis Source: Eur Respir J, 54 (2) 1900586; 10.1183/13993003.00586-2019 Year: 2019 Response to PAH specific therapy in systemic sclerosis patients with extensive parenchymal changes and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis Source: Eur Respir J 2016; 48: 1658-1667 Year: 2016 Vasodilator testing in pulmonary arterial hypertension associated with systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension Source: Eur Respir J, 52 (4) 1800678; 10.1183/13993003.00678-2018 Year: 2018 Predictors of pulmonary artery hypertension in patients with systemic sclerosis Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Incidence of new pulmonary hypertension and determining factors during follow-up of patients with systemic sclerosis after negative right heart catheterisation Source: International Congress 2017 – PAH and CTEPH Year: 2017 Pulmonary hypertension in systemic sclerosis: different phenotypes Source: Eur Respir Rev, 26 (145) 170056; 10.1183/16000617.0056-2017 Year: 2017 The change of lung diffusion capacity does not influence the prognosis in patients with pulmonary arterial hypertension associated with systemic sclerosis. Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Clinical and autoantibody features of right-heart catheter-proven pulmonary hypertension in systemic sclerosis Source: Eur Respir J 2002; 20: Suppl. 38, 371s Year: 2002 Screening for pulmonary arterial hypertension in systemic sclerosis Source: Eur Respir Rev 2009; 18: 162-169 Year: 2009 Ventricular mass index correlates with pulmonary haemodynamics in patients with systemic sclerosis and suspected pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Systematic cardiac echoscreening is effective in detecting early stage pulmonary arterial hypertension in systemic sclerosis Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Does left heart disease cause most systemic sclerosis associated pulmonary hypertension? Source: Eur Respir J 2013; 42: 888-890 Year: 2013